Zezhi Jesse Shao,Anthony C. Blackburn,Andrew J. Grottick,Michael E. Morgan,Jaimie Karyn Rueter,Anna Shifrina,Scott Stirn,Libo Yang,Woo Hyun Yoon
申请号：
US15429221
公开号：
US10226471B2
申请日:
2017.02.10
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
